In a couple past columns we briefly mentioned a study by
McHugh and Stimpfel (McHugh
2012) which showed nurses’ ratings of hospital quality and safety
correlate well with more formal measures. Now a new study done in Swedish
hospitals extends upon that work (Smeds-Alenius
2016). The study used
a survey of nurses in 67 Swedish hospitals and covered over 200,000 general,
vascular, and orthopedic surgical procedures. The researchers found that
hospitals in the highest tertile of nurses reporting
excellent quality of care had a 23% lower odds of 30-day inpatient mortality.
Similarly, hospitals in the highest tertile of nurses
reporting excellent patient safety had a 26% lower odds of 30-day inpatient
mortality. The study validates the previous work of McHugh and Stimpfel and suggests that nurses’ assessments could be
used as legitimate measures of quality and patient safety. The authors do recognize
that inpatient mortality is a crude measure of both safety and quality (Lilford
2010, Girling 2012). Mortality rates may be appropriate
indicators for some conditions but not others. Moreover, patient-related
factors and patient socioeconomic factors, advance directive issues, plus other
factors impact inpatient mortality rates. Even after risk adjustment for
patient-related variables, mortality rates may be less than ideal measures of
quality or patient safety. The current study was done in Sweden supposedly to minimize
some of the confounding factors seen in the US such as variation in insurance
status and correlated health status.
So could nurse
assessment be used as a formal measure of quality and patient safety? We would
have no qualms about using nurse assessments as an informal measure and we do often
ask nurses their opinion on quality and patient safety in their hospitals. It
might help inform us in our decisions about whether to have a procedure at
their hospital. However, what is unknown is what would happen to the observed
correlation between nurse assessment and mortality rates if this were to become
a formal measure of quality and patient safety. Would nurses continue to
provide honest assessments if they knew that the very viability of their
hospital might be jeopardized by public disclosure of such assessments? We may
never know the answer to that question.
But when we are
asked by someone what is the best way to tell whether a hospital has good
quality and safety we have no problem telling them “ask a nurse”!
References:
McHugh MD, Stimpfel AW. Nurse reported quality of care: A measure of
hospital quality.
Research in Nursing & Health 2012; Article first published online:
21 AUG 2012
http://onlinelibrary.wiley.com/doi/10.1002/nur.21503/abstract
Smeds-Alenius L, Tishelman
C, Lindqvist R, Runesdotter
S, McHugh MD. RN assessments of excellent quality of care and patient safety
are associated with significantly lower odds of 30-day inpatient mortality: A
national cross-sectional study of acute-care hospitals. International Journal of
Nursing Studies 2016; 61: 117–124
http://www.journalofnursingstudies.com/article/S0020-7489%2816%2930075-X/fulltext
Lilford R, Pronovost P. Using
hospital mortality rates to judge hospital performance: a bad idea that just
won't go away. BMJ 2010; 340: c2016
Girling AJ, Hofer TP, Wu J, et al. Case-mix adjusted
hospital mortality is a poor proxy for preventable mortality: a modelling
study. BMJ Qual
Saf 2012; 21(12): 1052-1056 Published Online
First: 15 October 2012
http://qualitysafety.bmj.com/content/21/12/1052.full?sid=53664ed3-dc01-47d1-8be8-d33be15c7132
Print “October
2016 Hospital Quality? Ask a Nurse”
Since the 1990’s one of the key components of “clinical
pathways” for cardiac surgery has been early extubation
of patients, often protocol-based. That was a key to reducing ICU lengths of
stay for such patients.
Indeed, one study heavily weighted toward cardiothoracic
surgery patients (Tischenkel 2016)
found that intensive care unit extubations at night
did not have higher likelihood of reintubation, LOS, or mortality compared to
those during the day. In fact, trends in that study favored nighttime extubation for both reintubation rates and mortality and
those extubated at night had significantly lower lengths of stay.
Given the complications associated with mechanical
ventilation and extended intubation, it might seem wise that patients should be
extubated as soon as possible. Those complications include ventilator-associated
pneumonias, delirium, neuromuscular syndromes, etc. Hence, there might be
theoretical reasons to favor early extubation. But
what are the empirical data favoring overnight extubation?
A new study looks at patient outcomes in patients who were extubated overnight
and has some surprising results (Gershengorn
2016). In a retrospective analysis of a cohort of almost 100,000
mechanically ventilated patients they found 20.1% were extubated overnight and
that rate has decreased over time. For those patients who had been mechanically
ventilated for less than 12 hours reintubation rates were similar between those
extubated overnight vs. during the daytime but
mortality was increased for those extubated overnight (5.6% vs. 4.6%). For
those mechanically ventilated more than 12 hours, those extubated overnight had
higher reintubation rates and higher ICU and hospital mortality with no
difference in length of stay.
One intriguing finding was that the odds ratios for
increased mortality in those extubated overnight were higher than the odds
ratios for reintubations. While several possible reasons were discussed by the
authors, they favored a hypothesis that “palliative” extubations
may have accounted for this (with the theory that palliative extubations are more likely to take place when family is
present at night).
They also attributed the disparity between their study and
that by Tischenkel and colleagues (Tischenkel 2016)
to a significant difference in the number of patients undergoing cardiothoracic
surgery.
Keep in mind that the Gershengorn
study was a retrospective cohort study. As pointed out in the accompanying
editorial (Moore
2016), though the study had excellent data collection as part of a large
collaborative study there was lack of information on the circumstances and
reasons for extubation (and reasons why some were not
reintubated).
In our September 20,
2016 Patient Safety Tip of the Week “Downloadable
ABCDEF Bundle Toolkits for Delirium” we discussed a study (Balas
2013a , Balas 2014) that was a prospective, cohort,
before-after study of the ABCDE bundle at a large, tertiary medical center,
involving patients from multiple ICU’s. They found patients treated with the
ABCDE bundle, which leads to earlier extubation,
experience more days breathing without assistance and a shorter duration of ICU
delirium. The odds of delirium were cut almost in half. Patients on the bundle
were also more likely to be mobilized out of bed during their ICU stay. No
significant differences were noted in self-extubation
or reintubation rates. But it should be noted that one of the barriers
encountered in implementation was that nurses and respiratory therapists were
often concerned about spontaneous breathing trials being done at night (Balas
2013b).
Though the findings of the Gershengorn
study are associations and do not prove causality, they certainly put to
question the practice of overnight extubations. We
suspect that there may well be differences in outcomes both by type of ICU and
nature of the underlying problem. But it is certainly worth all hospitals
taking a look at their current practices and outcomes.
References:
Tischenkel BR, Gong MN, Shiloh AL, et al.
Daytime vs nighttime extubations: a comparison
of reintubation, length of stay, and mortality. J Intensive Care Med 2016;
31(2): 118-126
http://jic.sagepub.com/content/31/2/118
Gershengorn HB, Scales DC, Kramer
A, Wunsch H. Association between Overnight Extubations and Outcomes in the Intensive Care Unit. JAMA
Intern Med 2016; Published Online First September 06, 2016
http://archinte.jamanetwork.com/article.aspx?articleid=2547203
Moore PK, Matthay MA. Overnight Extubation in Patients with Mechanical Ventilation. Is It
Harmful? JAMA Intern Med 2016; Published online September 06, 2016
http://archinte.jamanetwork.com/article.aspx?articleid=2547200
Balas M, Olsen K, Gannon D, et al. Safety And
Efficacy Of The ABCDE Bundle In Critically-Ill Patients Receiving Mechanical
Ventilation. Abstract at Society of Critical Care Medicine 42nd
Critical Care Congress. Presented January 20, 2013. Crit
Care Med 2012; 40(12) (Suppl.): 1
Balas MC, Vasilevskis
EE, Olsen KM, et al: Effectiveness and safety of the awakening and breathing
coordination, delirium monitoring/management, and early exercise/mobility
bundle. Crit Care Med 2014; 42: 1024-1036
Balas MC, Burke WJ, Gannon D, et
al. Implementing the awakening and breathing coordination, delirium monitoring/management,
and early exercise/mobility bundle into everyday care: opportunities,
challenges, and lessons learned for implementing the ICU Pain, Agitation, and
Delirium Guidelines. Crit Care Med 2013; 41(9 Suppl
1): S116-127
Print “October
2016 Are Overnight Extubations Safe?”
It’s been over 4 years since the first warnings appeared
about the dangers of using codeine in children. Our previous 5 columns on the
dangers of codeine in children discussed the multiple safety alerts from the
FDA (FDA 2012, FDA 2013, FDA 2015). These
columns described cases of death and serious adverse effects in children
treated with codeine following adenotonsillectomy for
obstructive sleep apnea. The problem originally noted for codeine was that there
are genetic variations that cause some people to be “ultra-rapid metabolizers”
of codeine, which leads to higher concentrations of morphine in the blood
earlier.
In our January 2016 What's
New in the Patient Safety World column “FDA
Gets Even Tougher on Codeine in Kids” we noted that an advisory committee to the FDA recommended that
codeine be contraindicated for pain and cough management in children and
adolescents (Firth
2015). They also recommended restricting codeine's over-the-counter
availability for this group. Of 29 voting members, 20 voted to contraindicate
use of the drug for pain and cough in children younger than 18 years old. Most
of the others voted to restrict its use only in younger children. However, the
FDA has not yet taken formal action on those recommendations.
While the initial warnings focused on avoiding codeine in
children who were undergoing adenotonsillectomy for
obstructive sleep apnea (OSA), the dangers apply more globally to children. Now
an even tougher stance is being taken by the American Academy of Pediatrics in
a statement “Codeine: Time to Say ‘No’ ” (Tobias
2016). That paper reiterates the evidence of adverse effects of codeine in
children and their mechanisms. It notes that codeine is still available in
over-the-counter cough formulas in 28 states and the District of Columbia
without a prescription.
The Tobias paper does discuss the pros and cons of
alternatives to codeine in the pediatric population, noting that almost all of
them also have some potential downsides. Those alternatives include oxycodone,
hydrocodone, oral morphine, and tramadol. It also mentions tapentadol,
which is not yet FDA-approved for use in children. It notes that use of acetaminophen
and nonsteroidal antiinflammatory drugs (NSAIDs) are
legitimate alternatives in many or most children. Regarding the continued
presence of codeine in many antitussive formulations, it notes that neither the
value of suppressing cough nor the effectiveness of codeine in children with
acute illnesses has been shown.
Our May 2014 What's
New in the Patient Safety World column “Pediatric
Codeine Prescriptions in the ER” noted the continued frequent prescription
of codeine-containing products in children despite the previous warnings about
adverse reactions. In our November 2015 What's New in
the Patient Safety World column “FDA
Safety Communication on Tramadol in Children” we noted that education does not seem to have reduced prescription of
codeine-containing products. We therefore advocated incorporating “hard stops”
(alerts requiring acknowledgement of the warnings about codeine or other opioid
in children) into CPOE and e-prescribing systems. We would hope that the FDA takes
more forceful action, as recommended by the previous advisory committee and the
current American Academy of Pediatrics, to reduce the risk of codeine-associated respiratory depression and
other adverse events.
Regardless of whether the FDA takes action or not, you
should be monitoring your organization’s prescription of codeine-containing
products and taking active steps (like the hard stops noted above) to force
your prescribers to think twice when contemplating use of codeine in children.
Some of our previous
columns on opioid safety issues in children:
References:
FDA. FDA Drug Safety
Communication: Codeine use in certain children after tonsillectomy and/or
adenoidectomy may lead to rare, but life-threatening adverse events or death.
8/15/12
http://www.fda.gov/Drugs/DrugSafety/ucm313631.htm
FDA. FDA Drug Safety Communication: Safety review update of
codeine use in children; new Boxed Warning and Contraindication on use after
tonsillectomy and/or adenoidectomy. Update February 20, 2013
http://www.fda.gov/Drugs/DrugSafety/ucm339112.htm
FDA (Food and Drug Administration) Briefing Document: The
safety of codeine in children 18 years of age and younger. Joint
Pulmonary-Allergy Drugs Advisory Committee and Drug Safety and Risk Management
Advisory Committee Meeting . December 10, 2015
Firth S. FDA Panel Urges Stronger Regulation of Codeine. An
FDA advisory committee voted 28-0 to remove the drug from its OTC monograph for
cough and cold. MedPage Today 2015; December 11, 2015
http://www.medpagetoday.com/Pediatrics/GeneralPediatrics/55159
Tobias JD, Green TP, Coté CJ,
Section on Anesthesiology and Pain Medicine, Committee on Drugs. Codeine: Time
to Say “No”. Pediatrics 2016; Originally published
online September 19, 2016
http://pediatrics.aappublications.org/content/early/2016/09/15/peds.2016-2396
Print “October
2016 Another Codeine Warning for Children”
One of our columns that
surprisingly is near the top of our “hit” list was our November 1, 2011 Patient
Safety Tip of the Week “So
What’s the Big Deal About Inserting an NG Tube?”. In
that column we noted that nasogastric tube (NG tube) insertion is so common
that we tend to forget its risks. But if you’ve ever seen a patient die because
their enteral feeds were inadvertently given into their lungs or develop
meningitis because the NG tube went through a basal skull fracture, you won’t
take this cavalier attitude toward NG tubes. We noted 3 Patient Safety Alerts
from the UK’s NPSA (NPSA
2005a, NPSA
2005b, NPSA
2011) that reported numerous incidents, including deaths and other bad outcomes
related to misplaced NG tubes.
Feeding tube misplacement is an issue not just in the UK. The
American Association of Critical-Care Nurses issued a press release (AACN
2016) on September 15, 2016 calling attention to their practice alert “Initial
and Ongoing Verification of Feeding Tube Placement in Adults” issued earlier
this year. According to that new guideline, the expected practice during the insertion
procedure is to use a combination of two or more of the following bedside methods
to predict tube location:
Confirmation by radiography is still the most important
element but results of the above elements can be used to determine when it is
time to use radiography to confirm tube location and they may also be able to
reduce the number of confirming radiographs to one.
Just as important, the alert discusses methods of tube
location that should not be used. It stresses that nurses should not use the auscultatory (air
bolus) or water bubbling method (holding tube under water) to determine
tube location.
It also has important considerations for the radiologic
confirmation of tube location. Correct placement of a blindly inserted
small-bore or large-bore tube should be confirmed with a radiograph that visualizes the entire course of the tube prior to
its initial use for feedings or medication administration. Once correct tube
placement is confirmed, the exit site from the patient’s nose or mouth should
be immediately marked and documented to assist in subsequent determinations of
tube location. After feedings are started, tube location should be checked at
four-hour intervals.
The practice alert is well-referenced, both in terms of
citing the literature on adverse effects of tube misplacement and the
supporting evidence for the recommended best practices.
We refer you back to
our November 1, 2011 Patient Safety Tip of the Week “So
What’s the Big Deal About Inserting an NG Tube?”
for other lessons learned and other issues regarding NG and other feeding
tubes. Pay particular attention to the section on radiologic confirmation.
First, the x-ray requisition should clearly state the x-ray is for determination
of tube placement. All too often we still see x-ray requisitions filled out
with something like the admission diagnosis rather than the real reason for the
x-ray. And you need to make sure that the person doing the interpretation is appropriately
credentialed to do so (for example, if someone other than the radiologist is
doing the interpretation). And feeding should not be commenced via that tube
until the radiologist (or appropriately credentialed person) has documented the
tube is in the correct location.
References:
AACN (American Association of Critical-Care Nurses). Feeding
Tubes Require Initial and Ongoing Verification to Minimize Complications.
American Association of Critical-Care Nurses updates Practice Alert on feeding
tube placement. Press Release 15-Sep-2016
AACN (American Association of Critical-Care Nurses). AACN
Practice Alert: Initial and Ongoing Verification of Feeding Tube Placement in
Adults. CriticalCareNurse 2016; 36(2): e8-e13 April 2016
http://www.aacn.org/wd/practice/content/feeding-tube-practice-alert.pcms?menu=practice
Print “October
2016 AACN Alert on Feeding Tube Placement”
One of the questions addressed before anyone gets an MRI
scan is whether the patient has any sort of implant or device or foreign body
that may be adversely affected by the magnetic fields. Sounds simple, doesn’t
it? Don’t we just look at a list of those items that would contraindicate an
MRI scan?
Well, it is not so simple. Dr. Emanuel Kanal, director of MR services at University of Pittsburgh
Medical Center and a well-known expert on MRI safety issues, has developed the MR
Safety Implant Risk Assessment app on the IOS (iPhone) platform to address
the multiple factors involved. A recent interview with him on AuntMinnie.com,
the popular radiology website, discussed the details and intricacies of the app
(Ridley
2016).
Factors affecting
the safety during MRI include not only the type of implant but also its
location, the type of MRI scan being done, the part of the body being imaged,
the strength of the magnet and other issues of configuration of the MRI
machine, and other considerations such as the location of the various energy
sources relative to the patient’s location in the MRI suite. Kamal notes that what
is safe in one system may not be safe in another. Moreover, a patient might
safely have one part of the body imaged by MRI but not another. Importantly,
some patients may be being denied potentially helpful MRI scanning that could
be safely performed given the correct type of study and equipment.
The intended
audience for the app is MR technologists, radiologists, or MR physicists and it
requires technical knowledge about MRI. Kamal describes the app as a teaching
tool in addition to its practical utility in determining whether a patient can
be safely imaged by MR. Kamal, who is also a licensed pilot, describes the
checklist format that forces the user to consider all the potential safety
concerns before concluding that the patient may have the MR study safely
performed.
The interview is
worth your reading and you should make sure that those involved in your MRI
unit know about the nature and availability of the app. But the interview was
enlightening even for those of us lacking the technical MR expertise. As a
neurologist, I highly suspect after reading it that there have been instances
where I referred patients for alternative imaging modalities when an MRI
actually could have been performed safely.
Speaking of safety in the MRI suite, we should also note
that a coalition of societies and organizations dealing with MRI has proposed a
delineation of responsibilities for the management of MRI facilities (Calamante
2016).
Some of our prior
columns on patient safety issues related to MRI:
References:
Ridley EL. Mobile App Spotlight: Kanal's
MR safety implant risk tool. AuntMinnie.com 2016; August 24, 2016
http://www.auntminnie.com/index.aspx?sec=sup&sub=mri&pag=dis&ItemID=114953
Apple iTunes store. Kanal's MR
Safety Implant Risk Assessment (app).
https://itunes.apple.com/us/app/kanals-mr-safety-implant-risk/id1114168862
Calamante F, Ittermann
B, Kanal E, The Inter-Society Working Group on MR
Safety and Norris D. Recommended responsibilities for management of MR safety.
JMRI 2016; Early View 3 Jun 2016
http://onlinelibrary.wiley.com/doi/10.1002/jmri.25282/epdf
Print “October
2016 MRI Safety: There’s an App for That!”
Print “October
2016 What's New in the Patient Safety World (full
column)”
Print “October
2016 Hospital Quality? Ask a Nurse”
Print “October
2016 Are Overnight Extubations Safe?”
Print “October
2016 Another Codeine Warning for Children”
Print “October
2016 AACN Alert on Feeding Tube Placement”
Print “October
2016 MRI Safety: There’s an App for That!”
Print “PDF
version”
http://www.patientsafetysolutions.com/